Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Cutaneous Squamous Cell Carcinoma”

41 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 41 results

Early research (Phase 1)WithdrawnNCT07100925
What this trial is testing

Tolododekin Alfa (ANK-101) in Renal Allograft Recipients With High Risk Cutaneous Squamous Cell Carcinoma

Who this might be right for
Cutaneous Squamous Cell Carcinoma (CSCC)Renal TransplantSolid Tumor+1 more
Ankyra Therapeutics, Inc
Very early researchLooking for participantsNCT06305962
What this trial is testing

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

Who this might be right for
PDL1 Gene MutationNon Small Cell Lung CancerSmall Cell Lung Cancer ( SCLC )+6 more
Radiopharm Theranostics, Ltd 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05286294
What this trial is testing

Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders

Who this might be right for
Melanoma Stage IVHead and Neck Squamous Cell CarcinomaCutaneous Squamous Cell Carcinoma+3 more
Oslo University Hospital 20
Testing effectiveness (Phase 2)WithdrawnNCT06084845
What this trial is testing

Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carboplatin for Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell CarcinomaHypopharyngeal Squamous Cell CarcinomaLaryngeal Squamous Cell Carcinoma+12 more
ECOG-ACRIN Cancer Research Group
Not applicableActive Not RecruitingNCT06046625
What this trial is testing

Needs and Preferences of Patients With Head-neck Cutaneous SCC

Who this might be right for
Cutaneous Squamous Cell CarcinomaCutaneous Squamous Cell Carcinoma of the Head and NeckSquamous Cell Carcinoma+8 more
Maastricht University Medical Center 15
Testing effectiveness (Phase 2)Study completedNCT03057613
What this trial is testing

The Addition of Pembrolizumab to Postoperative Radiotherapy in Cutaneous Squamous Cell Cancer of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Case Comprehensive Cancer Center 18
Testing effectiveness (Phase 2)Study completedNCT02347813
What this trial is testing

Preventing Squamous Cell Skin Cancer

Who this might be right for
Squamous Cell Carcinoma of the Skin
University of Rochester 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT04632433
What this trial is testing

Neoadjuvant Plus Adjuvant Treatment With Cemiplimab in Cutaneaous Squamous Cell Carcinoma

Who this might be right for
Cutaneous Squamous Cell Carcinoma
Fondazione Melanoma Onlus 25
Early research (Phase 1)Study completedNCT03894618
What this trial is testing

SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas

Who this might be right for
Squamous Cell Carcinoma of the Head and NeckMelanomaNon Small Cell Lung Cancer+10 more
Shattuck Labs, Inc. 49
Early research (Phase 1)Looking for participantsNCT05039801
What this trial is testing

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

Who this might be right for
Advanced Endometrial CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Malignant Solid Neoplasm+35 more
M.D. Anderson Cancer Center 54
Early research (Phase 1)Study completedNCT02635672
What this trial is testing

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

Who this might be right for
Neoplasms
Vincerx Pharma, Inc. 110
Testing effectiveness (Phase 2)Active Not RecruitingNCT04315701
What this trial is testing

A PD-1 Checkpoint Inhibitor (Cemiplimab) for High-Risk Localized, Locally Recurrent, or Regionally Advanced Skin Cancer

Who this might be right for
Recurrent Skin Squamous Cell CarcinomaResectable Skin Squamous Cell CarcinomaStage I Skin Cancer+2 more
University of Southern California 35
Not applicableUnknownNCT05845632
What this trial is testing

Time to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell Carcinoma

Who this might be right for
Carcinoma, Squamous CellSkin CancerCarcinoma, Squamous Cell, Skin+3 more
Maastricht University Medical Center 965
Large-scale testing (Phase 3)Looking for participantsNCT06692556
What this trial is testing

Study of a Strategy Integrating Adjuvant Radiation Therapy Versus Strategy Based on Monitoring in the Treatment of Carcinomas Spinocellular With High Risk of Recurrence

Who this might be right for
Cutaneous Squamous Cell Carcinoma (CSCC)
Centre Leon Berard 266
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Not applicableActive Not RecruitingNCT05724875
What this trial is testing

FLASH Radiotherapy for Skin Cancer

Who this might be right for
Basal Cell CarcinomaCutaneous Squamous Cell Carcinoma
Centre Hospitalier Universitaire Vaudois 60
Not applicableLooking for participantsNCT07746258
What this trial is testing

Testing Whether Skin Cancer Has Spread to Nearby Lymph Nodes

Who this might be right for
Cutaneous Squamous Cell Carcinoma (CSCC)
Germans Trias i Pujol Hospital 142
Large-scale testing (Phase 3)Active Not RecruitingNCT03969004
What this trial is testing

Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma

Who this might be right for
Cutaneous Squamous Cell Carcinoma
Regeneron Pharmaceuticals 415
Early research (Phase 1)Study completedNCT02020707
What this trial is testing

Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers

Who this might be right for
Cervical AdenocarcinomaCervical AdenosarcomaCervical Adenosquamous Carcinoma+45 more
Mayo Clinic 43
Large-scale testing (Phase 3)Looking for participantsNCT06992427
What this trial is testing

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell CarcinomaStage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8Stage II Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8+2 more
Alliance for Clinical Trials in Oncology
Next Page
228